This topic contains a solution. Click here to go to the answer

Author Question: A 62-year-old client presents with a complaint of fever, pain, and burning on urination. Difficulty ... (Read 70 times)

fasfsadfdsfa

  • Hero Member
  • *****
  • Posts: 554
A 62-year-old client presents with a complaint of fever, pain, and burning on urination. Difficulty urinating with dribbling has been increasing in the past few days. He has a feeling of pressure in his groin.
 
  On examination, his prostate is tender, boggy, and warm. A stat urinalysis reveals the presence of leukocytes and bacteria. He is allergic to sulfa drugs. His weight is 70 kg and his last serum creatinine was 1.0. While awaiting the culture and sensitivity, the nurse practitioner begins empiric treatment with which of the following?
  A. Trimethoprim/sulfamethroxazole DS bid x 2 weeks
  B. Ampicillin 250 mg PO q day for 10 days
  C. Nitrofurantoin 100 mg Q 12 hours for 7 days
  D. Ciprofloxacin 500 mg Q 12 hours for 14 days

Question 2

Known risk factors for lymphedema include all of the following except
 
  A. Osteoarthritis
  B. Rheumatoid arthritis
  C. Obesity
  D. Venous ulcer disease



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

14vl19

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

D

Answer to Question 2

A





 

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Medication errors are three times higher among children and infants than with adults.

For a complete list of videos, visit our video library